These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20962642)

  • 1. Steroids in neurooncology: actions, indications, side-effects.
    Roth P; Wick W; Weller M
    Curr Opin Neurol; 2010 Dec; 23(6):597-602. PubMed ID: 20962642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal insufficiency secondary to glucocorticoid withdrawal in patients with brain tumor.
    Da Silva AN; Schiff D
    Surg Neurol; 2007 May; 67(5):508-10. PubMed ID: 17445619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative steroids for peritumoral intracranial edema: a review of mechanisms, efficacy, and side effects.
    Bebawy JF
    J Neurosurg Anesthesiol; 2012 Jul; 24(3):173-7. PubMed ID: 22544067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated edema in brain cancer patients: pathogenesis and management.
    Roth P; Regli L; Tonder M; Weller M
    Expert Rev Anticancer Ther; 2013 Nov; 13(11):1319-25. PubMed ID: 24152171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.
    Panickar KS
    Curr Opin Mol Ther; 2010 Dec; 12(6):780-9. PubMed ID: 21154169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroids in head injury.
    Kelly DF
    New Horiz; 1995 Aug; 3(3):453-5. PubMed ID: 7496754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic, electrolytes disorders and tromboembolic risk in malignant glioma patients.
    Silvani A; Gaviani P; Lamperti E; Botturi A; Ferrari D; Simonetti G; Fariselli L; Salmaggi A
    Neurol Sci; 2011 Nov; 32 Suppl 2():S229-31. PubMed ID: 21993831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of corticosteroid on peritumor brain swelling and associated neurologic deficit.
    Weinstein J; Toy F; Goldberg HI; Jaffe ME
    Trans Am Neurol Assoc; 1970; 95():335. PubMed ID: 5514408
    [No Abstract]   [Full Text] [Related]  

  • 9. Seizures and brain tumors.
    Sperling MR; Ko J
    Semin Oncol; 2006 Jun; 33(3):333-41. PubMed ID: 16769422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy: a strategy for malignant gliomas' resistance to therapy.
    Ge P; Luo Y; Fu S; Ji X; Ling F
    Med Hypotheses; 2009 Jul; 73(1):45-7. PubMed ID: 19268486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of steroids in neuro-oncology].
    Barbero-Bordallo N; Gomez-Vicente L
    Rev Neurol; 2019 May; 68(9):389-397. PubMed ID: 31017292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical control trial of methylprednisolone and dexamethasone in treatment of intracranial tumor edema].
    Ding X; Mao B; Ju Y; Liu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):327-9. PubMed ID: 12947730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity to glucocorticoids in patients with raised ICP : report of two cases.
    Sharma RR; Pawar SJ; Dev EJ; Ebenezer S; Mahapatra AK
    Neurol India; 2001 Dec; 49(4):404-6. PubMed ID: 11799418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of glucocorticoid treatment in various forms of cerebral edema].
    Rosenørn J; Astrup J
    Ugeskr Laeger; 1981 Feb; 143(8):474-7. PubMed ID: 7010736
    [No Abstract]   [Full Text] [Related]  

  • 15. An overview of the adverse reactions to adrenal corticosteroids.
    Frauman AG
    Adverse Drug React Toxicol Rev; 1996 Nov; 15(4):203-6. PubMed ID: 9113247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EEG changes in response to dehydration depending on the extent of intracranial hypertension].
    Mosiĭchuk NM; Zorin NA; Chebanov KO; Mateĭ TV
    Zh Vopr Neirokhir Im N N Burdenko; 1988; (5):30-3. PubMed ID: 3145664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uses, adverse effects of abuse of corticosteroids. Part I.
    Imam AP; Halpern GM
    Allergol Immunopathol (Madr); 1994; 22(6):250-60. PubMed ID: 7892813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor decreases vasogenic brain edema.
    Tjuvajev J; Uehara H; Desai R; Beattie B; Matei C; Zhou Y; Kreek MJ; Koutcher J; Blasberg R
    Cancer Res; 1996 Mar; 56(6):1352-60. PubMed ID: 8640825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?
    Hempen C; Weiss E; Hess CF
    Support Care Cancer; 2002 May; 10(4):322-8. PubMed ID: 12029432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.